A name-brand prescription drug manufacturer can be held liable for injuries caused by the generic version of the drug made by another manufacturer, a California appellate court has ruled.
The ruling, which allows a lawsuit against Madison, N.J.-based Wyeth Inc. to go to trial, is the opposite of numerous other decisions on the issue and could create liability concerns for brand drug manufacturers if upheld, attorneys say.